ProgramAccelerate®
ProgramAccelerate is the third phase of our Trusted Process. This is where your project moves into high gear. Momentum builds with patient recruitment and patient monitoring. Data is proactively processed and assessed; ensuring project timelines and quality are actively managed. Successful management of your trial during ProgramAccelerate enables us to move towards a QualityFinish. |
Patient recruitment and retention is extremely important during this phase and is arguably one of the most challenging and time-sensitive elements to a clinical study. Particularly in trials with difficult indications or tight inclusion criteria, unexpected delays are, well, expected. To proactively mitigate risk, our patient recruitment specialists must not only develop an ideal patient enrollment plan, but also well thought-out contingency plans – within the financial parameters of the trial.
What sets INC Research apart is having one central specialized recruitment team managing every site for a complete picture of the study.
In addition, our dedicated project team is continually examining trials and data progress to determine key areas of interest in ProgramAccelerate. Queries that could affect future analysis and study closeout are resolved immediately.
At INC Research, it’s all about the process…our Trusted Process…our proven, metrics-driven methodology that delivers predictably dependable outcomes – created and perfected by us. By consistently delivering actionable results, we are able to support your critical drug development programs, on time and on budget.
|
Meet Tammy Ice, a ProgramAccelerate® Specialist
White Paper
How can key decision makers objectively evaluate their CRO partner relationships? What can be done to increase a trial's success?
Download our white paper >>
Company Materials
|
|
